Skip to main content
. 2009 Dec 18;66(3):547–558. doi: 10.1007/s00280-009-1195-2

Fig. 1.

Fig. 1

Dose-response cytotoxicity of oxaliplatin (L-OHP), pemetrexed (MTA) and their combinations in HT29, WiDr, SW620 and LS174T colon cancer cells. Data represent the mean percentage of proliferating cells (±SD) from three independent experiments. In combination experiments the values refer to oxaliplatin concentration